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Abstract
Objective
There is a paucity of research on patients presenting with uninfected diabetic foot ulcers
(DFU) that go on to develop infection. We aimed to investigate the incidence and risk factors
for developing infection in a large regional cohort of patients presenting with uninfected
DFUs.
Methods
We performed a secondary analysis of data collected from a validated prospective state-
wide clinical diabetic foot database in Queensland (Australia). Patients presenting for their
first visit with an uninfected DFU to a Diabetic Foot Service in one of thirteen Queensland
regions between January 2012 and December 2013 were included. Socio-demographic,
medical history, foot disease history, DFU characteristics and treatment variables were cap-
tured at the first visit. Patients were followed until their DFU healed, or if their DFU did not
heal for 12-months, to determine if they developed a foot infection in that period.
Results
Overall, 853 patients were included; mean(standard deviation) age 62.9(12.8) years, 68.0%
male, 90.9% type 2 diabetes, 13.6% indigenous Australians. Foot infection developed in
342 patients for an overall incidence of 40.1%; 32.4% incidence in DFUs healed <3 months,
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55.9% in DFUs healed between 3–12 months (p<0.05). Independent risk factors (Odds
Ratio (95% confidence interval)) for developing infection were: DFUs healed between 3–12
months (2.3 (1.6–3.3)), deep DFUs (2.2 (1.2–3.9)), peripheral neuropathy (1.8 (1.1–2.9)),
previous DFU history (1.7 (1.2–2.4)), foot deformity (1.4 (1.0–2.0)), female gender (1.5
(1.1–2.1)) and years of age (0.98 (0.97–0.99)) (all p<0.05).
Conclusions
A considerable proportion of patients presenting with an uninfected DFU will develop an
infection prior to healing. To prevent infection clinicians treating patients with uninfected
DFUs should be particularly vigilant with those presenting with deep DFUs, previous DFU
history, peripheral neuropathy, foot deformity, younger age, female gender and DFUs that
have not healed by 3 months after presentation.
Introduction
Diabetic foot infections are a well-recognised risk factor for hospitalisation and amputation
[1–5]. According to a recent meta-analysis one in every 30 hospitalised patients at any given
time is affected by a diabetic foot infection [6]. Additionally, patients with diabetes who
develop an infection have been reported to have a 155-fold increased risk of amputation com-
pared to those who do not [5]. Nearly all diabetic foot infections originate in a diabetic foot
ulcer (DFU) [3–6] and the prevalence of these infections in DFUs have been reported to range
between 25–60% [3–5, 7–10]. Although the critical nature and prevalence of infected DFUs
are well appreciated [1–10], the development of these infections in the first place has received
less attention [5, 11].
One prospective study of 1,666 diabetes patients reported a 9% incidence for developing a
foot infection over a two-year follow up period [5]. Furthermore, the same study indicated a
61% incidence for developing a foot infection over a similar two-year period in a subgroup of
247 patients with a DFU; however, this subgroup included patients presenting with a mix of
uninfected and infected DFUs [5]. Similarly, a small number of studies have investigated the
risk factors for developing a diabetic foot infection and report patients presenting with periph-
eral neuropathy, peripheral arterial disease, previous DFUs and deep DFUs are more likely to
develop diabetic foot infections [5, 11]. However, to our knowledge no study has specifically
investigated the incidence and risk factors for developing an infection in a population of
patients presenting with an uninfected DFU. Thus, the primary aim of this study was to inves-
tigate the incidence and risk factors for developing an infection in patients presenting with an
uninfected DFU. A secondary aim was to investigate the incidence of infection in patients with
different DFU types and different DFU healing time durations.
Materials and methods
Study design
This study was a secondary analysis of data collected from a validated prospective state-wide
clinical diabetic foot database in Queensland, Australia (Queensland High Risk Foot Form
Database [12, 13]). The study received multi-site ethical approvals from two Australian
Human Research Ethics Committees (HRECs); The Prince Charles Hospital (HREC/15/
QPCH/177) and the Queensland University of Technology (1500000700). Furthermore, the
Risk factors for diabetic foot infection
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study received legal approvals from the Queensland Statewide Diabetes Clinical Network Data
Access committee and a Queensland Public Health Act 2005 waiver (QCHO/009321/
RD006012) to use confidential de-identified information from the database for the purposes of
this study. Thus, individual consent was not required or available for this study.
Settings and participants
Queensland is the third largest Australian state in terms of population, second largest in area
and the most decentralised state with extremely diverse demography and geography [14].
Patients attending an outpatient Diabetic Foot Service in 13 of the 17 Hospital and Health Ser-
vice areas in Queensland for treatment have their diabetic foot clinical data captured at each
visit on a validated Queensland High Risk Foot Form (QHRFF) [12, 13, 15]. The QHRFF data
is then collated and cleaned in the centralised QHRFF database for DFU healing and recur-
rence clinical benchmarking and research purposes [12, 13].
Eligible patients for this study were patients attending an aforementioned Diabetic Foot
Service in Queensland for their first clinical visit that recorded an uninfected DFU between 1st
January 2012 and 31st December 2013. The first clinical visit was defined as the first date the
patient attended the Diabetic Foot Service between 1st January 2012 and 31st December 2013.
A patient may have attended the service prior to 2012; however, this data was not captured for
this study. A DFU was defined as a full thickness wound beneath the ankle on a patient with
diabetes [4, 12]. An uninfected DFU was defined according to the International Working
Group on the Diabetic Foot classification system as having no clinical signs or symptoms of
infection [16, 17]. Patients were then followed from their first clinical visit until their DFU
healed or if it did not heal for 12 months. Exclusion criteria included patients who did not
have their infection status recorded at their first clinical visit (baseline) or at follow up visits
prior to their DFU healing or if it did not heal prior to 12 months (follow up).
Variables collected
For the purposes of this study the explanatory variables were those collected using the QHRFF
at the patient’s first clinical visit. If data were missing for a variable, the second visit’s data was
used for that variable(s) if available, provided the second visit was within one month of the
first visit. The QHRFF data collection procedures, methods and definitions have been reported
in detail elsewhere [12, 13, 18]. In brief, the QHRFF has been reported to be valid and reliable
for the capture of multiple self-reported and clinically diagnosed variables when collected by
clinicians with a range of diabetic foot disease experience [12].
The self-reported variables included: demographic (age, sex, indigenous status and re-
sidential postcode); diabetes history (diabetes type, diabetes duration, glycated haemoglobin
(HbA1c) and blood glucose levels (BGLs) >15 mmol/L in the previous 14 days); medical his-
tory (hypertension, dyslipidaemia, cardiovascular disease, chronic kidney disease and smoking
status); foot disease history (previous foot ulcer and previous amputation); and past foot treat-
ment in the previous 14 days (by podiatrist, general practitioner, surgeon, physician, nurse,
orthotists or other) [12]. Patient’s postcode of residence was transformed into the social de-
terminant variables of socioeconomic status (according to the Australian Index of Relative
Social Disadvantage [19]) and geographical remoteness status (according to the Accessibility/
Remoteness Index of Australia [20]).
The clinically diagnosed variables included: foot risk factors (peripheral neuropathy (PN),
lack of protective sensation to a 10-gram monofilament on at least 2 of 3 plantar forefoot loca-
tions [21, 22]; peripheral arterial disease (PAD), toe systolic pressure <70 mmHg [21, 22]; foot
deformity, scored at least 3 points on a 6-point foot deformity score [22]; suspected acute
Risk factors for diabetic foot infection
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Charcot foot, red, hot, swollen, unilateral neuropathic foot joint without a DFU near the sus-
pected Charcot joint [22]); foot ulcer characteristics (ulcer surface area (mm2); grade and depth,
according to the University of Texas Diabetic Wound Classification System [4]; deep ulcers,
scored a 2 (“wound penetrating to tendon or capsule”) or 3 (“wound penetrating to bone or
joint”) [4]; and infection status according to the International Working Group on the Diabetic
Foot classification system [16, 17]) [12]. DFU treatment provided on the first clinical visit was
also recorded, including if the DFU was treated with: sharp debridement; appropriate wound
dressings; prescribed antibiotics; optimum offloading in a cast walker; appropriate footwear;
and patient education on DFU care [12, 22]. Lastly, foot ulcer healing time was captured and
defined by subtracting the date of first clinical visit (as defined above) from the date the ulcer
was recorded as healed (complete epithelialisation) [4, 12]. Ulcer healing time was categorised
into: i) healed<3 months (<90 days since first visit), ii) healed between 3–12 months (91–365
days), iii) not healed at 12 months (ulcer had not healed at 365 days since first clinical visit).
The primary outcome variable for this study was the development of a foot infection prior
to when the DFU healed or if the DFU did not heal then prior to 12-months after the first clini-
cal visit. Foot infection was defined according to the International Working Group on the Dia-
betic Foot classification system as at least two clinical signs or symptoms of infection in or
around the DFU including purulence, erythema, pain, tenderness, warmth and/or induration
[16, 17, 23]. Patients were also sub-grouped into the following types of DFU: neuropathic (PN
and no PAD), ischaemic (PAD and no PN), neuro-ischaemic (PN and PAD), post-surgical
(recent non-healed minor amputation procedure regardless of PN or PAD), other (none of the
aforementioned DFU types) or unknown (PN, PAD or post-surgical was not recorded). For
patients with multiple DFUs a combined surface area of the multiple DFU was calculated, and
the DFU type, grade, depth and treatment characteristics for the worst DFU used [12].
Statistical analyses
Statistical analyses were performed with IBM SPSS 23.0 Statistics for Windows (SPSS Inc., Chi-
cago, IL, USA) or GraphPad Software. Categorical variables were expressed as proportions (%)
and continuous variables were expressed as a mean (standard deviation (SD)). Incidence was
expressed as the proportion (%) of patients developing an infection of eligible patients; for
overall patients, different DFU types, and ulcer healing time categories. For categorical vari-
ables Pearson’s chi-squared tests were used to test for any differences between groups (p<0.05)
and Fisher’s exact test with Bonferroni corrections were used for post-hoc pairwise compari-
sons (p<0.005) [24, 25]. For continuous variables analysis of variance (ANOVA) with Tukey’s
post-hoc test used were used to test for differences between groups (p<0.05) [24, 25]. Univari-
ate logistic regression analyses were used to test for crude associations (p<0.1) [26]. All vari-
ables achieving a crude association were included in a multivariate logistic regression analysis
to test for independent risk factors [26]. A backwards stepwise method was used to remove
non-significant variables (p>0.05) at each step until only variables reaching statistical signifi-
cance remained (p<0.05) [26, 27]. If collinearity was identified using a correlation matrix
(>0.9) the variables with the lowest odds ratio was excluded [26]. Hosmer and Lemeshow
goodness of fit, Omnibus degrees of freedom, Negelkerke pseudo R2 tests and significance
were assessed at each step [26, 27]. Missing data were treated by excluding cases with missing
data as the proportion of missing data were<5% in the model [26].
Results
Overall, 922 patients were eligible for inclusion in this study. Of these 69 (7.5%) patients were
excluded: 53 (5.7%) because their infection status was not recorded at baseline and 16 (1.7%)
Risk factors for diabetic foot infection
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because their infection status was not recorded on follow up. The remaining 853 included
patients had a mean age (SD) of 62.9 (12.8) years, 68.0% were male, 13.6% were indigenous
and 90.9% had type 2 diabetes. After the 12 month follow up period 454 (53.2%) patients’
DFUs healed<3 months, 222 (26.0%) healed between 3–12 months and 177 (20.8%) had not
healed at 12 months.
Table 1 displays the patient characteristics for the different DFU types: 316 (37.0%) had
neuropathic, 242 (28.4%) neuro-ischemic, 53 (6.2%) ischemic, 68 (8.0%) post-surgical, 41
(4.8%) other and 133 (15.6%) unknown DFU types. Differences between patients with differ-
ent DFU types included: ischaemic ulcer patients were of older age (p<0.05), more had hyper-
tension and cardiovascular disease, and fewer had previous foot ulcers (all p<0.005); neuro-
ischaemic ulcer patients were also of older age (p<0.05), more had chronic kidney disease,
previous amputations and past foot treatment from an orthotist (all p<0.005); post-surgical
ulcer patients had larger ulcer surface areas (p<0.05) and more had previous amputations
(p<0.005); other ulcer patients had fewer males, foot deformities, optimum offloading treat-
ment and appropriate footwear treatment (all p<0.005); and, patients with unknown ulcer
types had fewer BGLs >15 mmol/L, hypertension, dyslipidaemia, CVD and smokers, and
more had previous foot ulcers (all p<0.005). Although no differences existed for diabetes dura-
tion and HbA1c, it is noted that data on these two variables were missing in >50% of patients.
Table 1 also shows 342 patients developed a foot infection during follow up for an overall
incidence of 40.1%; including 32.4% incidence in DFUs healed<3 month, 55.9% in DFUs
healed between 3–12 month and 40.1% in DFUs that had not healed at 12 months (p<0.05).
However, there were no differences in foot infection incidence between different DFU types
(p>0.05).
Table 2 displays the univariate analyses that were conducted on the 720 patients with
known DFU types. We excluded the 133 patients with unknown DFU types from the univari-
ate analyses as they recorded large amounts of missing foot-related data, but in the other
demographic, social determinant, diabetes history, past foot treatment and treatment variables
with limited missing data they reported very few differences compared to known DFU types
(p>0.05) (Table 1). The variables that achieved a crude univariate association and were in-
cluded in the multivariate logistic regression model were age, sex, previous foot ulcer, periph-
eral neuropathy, foot deformity, deep ulcer and ulcer healing time (p<0.1).
Table 3 displays the independent risk factors (Odds Ratio (95% confidence interval)) that
predicted infection from the multivariate model and included: ulcers healed between 3–12
months (2.3 (1.6–3.3)), deep ulcers (2.2 (1.2–3.9)), peripheral neuropathy (1.8 (1.1–2.9)), pre-
vious foot ulcers (1.7 (1.2–2.4)), foot deformity (1.4 (1.0–2.0)), female gender (1.5 (1.1–2.1))
and years of age (0.98 (0.97–0.99)) (all p<0.05). The above multivariate model explained
approximately 12.0% of the variance of the infection outcome (Nagelkerke pseudo R2 = 0.120;
p<0.001).
Discussion
We found a 40% incidence of developing an infection prior to healing in a large sample of
patients presenting with uninfected DFUs across a large representative region of Australia.
The incidence increased from 32% in ulcers healed within 3 months to 56% in ulcers healed
between 3–12 months. However, there was no statistical differences in the incidence of devel-
oping an infection between different types of DFUs. We identified several independent risk
factors that predicted infection in patients presenting with an uninfected DFU, including pre-
senting with a deep ulcer, a previous DFU history, peripheral neuropathy, foot deformity, at a
younger age and female gender. Furthermore, DFUs that had not healed by 3 months after
Risk factors for diabetic foot infection
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Table 1. Participant characteristics for each diabetic foot ulcer type (number (%) unless otherwise stated).
n All Neuropathic Ischaemic Neuro-Ischaemic Post-Surgical Other Unknown p Value
Patients 853 853 316 53 242 68 41 133
Demographics
Age years (SD) 853 62.9(12.8) 59.2(12.6) 68.7(9.8)** 67.4(11.4)** 60.2(12.0) 58.7(14.7) 63.6(12.8) <0.001*
Age range years 27–92 28–89 48–90 27–90 40–92 27–87 32–92
Male sex 846 575 (68.0%) 211 (67.2%) 35 (66.0%) 172 (71.1%) 54 (79.4%) 19 (48.7%)** 84 (64.6%) 0.027*
Indigenous 521 71 (13.6%) 30 (13.4%) 2 (5.9%) 21 (12.7%) 8 (14.0%) 5 (18.5%) 5(35.7%) 0.145
Social Determinants
Socioeconomic Status 846 846 314 51 240 68 41 132
Most disadvantaged 199 (23.5%) 88 (28.0%) 8 (15.7%) 58 (24.2%) 10 (14.7%) 8 (19.5%) 27 (20.5%)
Second most disadvantaged 188 (22.2%) 63 (20.1%) 14 (27.5%) 51 (21.3%) 14 (20.6%) 11 (26.8%) 35 (26.5%)
Middle 130 (15.4%) 41 (13.1%) 8 (15.7%) 40 (16.7%) 15 (22.1%) 4 (9.8%) 22 (16.7%)
Second least disadvantaged 241 (28.5%) 83 (26.4%) 21 (41.2%) 71 (29.6%) 17 (25.0%) 16 (39.0%) 33 (25.0)
Least disadvantaged 88 (10.4%) 39 (12.4%) 0 20 (8.3%) 12 (17.6%) 2 (4.9%) 15 (11.4%) 0.497
Geographic Remoteness 846 846 314 51 240 68 41 132
Major city 373 (44.1%) 144 (45.9%) 18 (35.3%) 93 (38.8%) 33 (48.5%) 17 (41.5%) 68 (51.5%)
Inner regional area 165 (19.5%) 57 (18.2%) 13 (25.5%) 50 (20.8%) 14 (20.6%) 9 (22.0%) 22 (16.7%)
Outer regional area 194 (22.9%) 71 (22.6%) 14 (27.5%) 60 (25.0%) 13 (19.1%) 12 (29.3%) 24 (18.2%)
Remote area 66 (7.8%) 16 (5.1%) 4 (7.8%) 25 (10.4%) 5 (7.4%) 3 (7.3%) 13 (9.8%)
Very remote area 48 (5.7%) 26 (8.3%) 2 (3.9%) 12 (5.0%) 3 (4.4%) 0 5 (3.8%) 0.261
Diabetes History
Type 2 diabetes 853 775 (90.9%) 283 (89.6%) 51 (96.2%) 224 (92.6%) 62 (91.2%) 37 (90.2%) 118 (88.7%) 0.537
Duration years (SD) 365 19.7(11.0) 19.1(9.4) 19.1(12.4) 21.9(12.5) 17.0(10.6) 14.6(11.7) 20.6(7.3) 0.056
HbA1c % (SD) 220 8.4(2.0) 8.7(2.1) 7.3(1.4) 8.3(2.0) 8.4(1.7) 8.8(3.1) 7.8(1.8) 0.270
HbA1c mmol/mol a 220 68 72 56 67 68 73 62 0.270
BGL >15mmol/L 762 130 (17.1%) 62 (22.1%) 8 (16.0%) 33 (14.7%) 9 (15.0%) 9 (25.0%) 9 (8.1%)** 0.015*
Medical History
Hypertension 853 211 (24.7%) 88 (27.8%) 29 (54.7%)** 53 (21.9%) 18 (26.5%) 17 (41.5%) 6 (4.5%)** <0.001*
Dyslipidaemia 853 139 (16.3%) 54 (17.1%) 10 (18.9%) 51 (21.1%) 12 (17.6%) 7 (17.1%) 5 (3.8%)** 0.001*
CVD 853 90 (10.6%) 24 (7.6%) 18 (34.0%)** 37 (15.3%) 6 (8.8%) 4 (9.8%) 1 (0.8%)** <0.001*
CKD b 853 60 (7.0%) 22 (7.0%) 5 (9.4%) 29 (12.0%)** 1 (1.5%) 0 3 (2.3%) 0.001*
Smoker 853 37 (4.3%) 19 (6.0%) 3 (5.7%) 7 (2.9%) 5 (7.4%) 3 (7.3%) 0** 0.035*
Past Foot Treatment
Podiatrist 853 800 (93.8%) 293 (92.7%) 51 (96.2%) 227 (93.8%) 60 (88.2%) 40 (100%) 128 (96.2%) 0.115
GP 853 20 (2.3%) 10 (3.2%) 1 (1.9%) 5 (2.1%) 2 (2.9%) 1 (2.4%) 1 (0.8%) 0.755
Surgeon 853 14 (1.6%) 8 (2.5%) 0 3 (1.2%) 2 (2.9%) 0 1 (0.8%) 0.450
Physician 853 21 (2.5%) 14 (4.4%) 0 6 (2.5%) 0 0 1 (0.8%) 0.055
Nurse 853 53 (6.2%) 18 (5.7%) 4 (7.5%) 18 (7.4%) 7 (10.3%) 2 (4.9%) 4 (3.0%) 0.375
Orthotist 853 8 (0.9%) 1 (0.3%) 0 7 (2.9%)** 0 0 0 0.015*
Other 853 20 (2.3%) 10 (3.2%) 1 (1.9%) 9 (3.7%) 0 0 0 0.118
Foot Disease History
Previous foot ulcer 853 595 (69.8%) 202 (63.9%) 30 (56.6%)** 184 (76.0%) 46 (67.6%) 26 (63.4%) 107 (80.5%)** 0.001*
Previous amputation 852 242 (28.4%) 74 (23.5%) 5 (9.4%) 83 (34.3%)** 40 (58.8%)** 7 (17.1%) 33 (24.8%) <0.001*
Foot Risk Factors
Peripheral Neuropathy 726 617 (85.0%) 316 (100%) 0** 242 (100.0%) 53 (80.3%) 0** 6 (75.0%) <0.001*
PAD 720 330 (45.8%) 0** 53 (100.0%) 242 (100.0%) 32 (49.2%)** 0** 3 (100.0%) <0.001*
Foot deformity 728 460 (63.2%) 209 (66.1%) 24 (45.3%) 159 (66.0%) 47 (72.3%) 13 (32.5%)** 8 (61.5%) <0.001*
Acute Charcot Foot 723 18 (2.5%) 13 (4.1%) 0 4 (1.7%) 0 1 (2.5%) 0 0.191
Foot Ulcer Characteristics
Ulcer area mm2 (SD) c 740 235.7(610.4) 184.7(449.2) 210.5(351.6) 226.3(594.8) 585.8(941.3)** 394.3(1317.7) 163.0(488.2) <0.001*
(Continued)
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presentation were also a significant risk factor for infection. This study confirms, that regard-
less of the type of DFU presenting, a considerable proportion of people with DFUs will develop
an infection prior to healing and common risk factors predict these infections.
To our knowledge only a paper by Lavery and colleagues (2006) has previously investigated
the incidence of diabetic foot infection [5]. Lavery reported a 9% incidence of foot infection
over a two-year follow up period in 1,666 patients with diabetes who were at different risks of
developing DFU (low or high risk) [5]. They also indicated a 61% incidence of infection in a
subgroup of 247 patients who developed a DFU (presenting with or without infection) [5].
Our study found a 40% incidence of infection over a one-year follow up period in 853 patients
who first presented with an uninfected DFU. Additionally we found the incidence increased
from 32% for ulcers healed <3 months to 56% for ulcers healed between 3–12 months; how-
ever, the incidence for ulcers not healed at 12 months was no higher than those healed <12
months. Furthermore whilst not ideal, comparing our 32–56% incidence findings to the 26–
60% infection prevalence range reported by numerous DFU studies, seems to add further plau-
sibility to our findings [3–5, 7–10]. Overall, interpreting these incidence findings together sug-
gests the chance of developing an infection is double in those with “non-healing ulcers” (>3
months healing time) compared to “healing ulcers” (<3 months) [5, 10].
Table 1. (Continued)
n All Neuropathic Ischaemic Neuro-Ischaemic Post-Surgical Other Unknown p Value
Deep ulcer d 843 66 (7.8%) 20 (6.5%) 2 (3.8%) 18 (7.5%) 9 (13.2%) 5 (12.8%) 12 (8.9%) 0.333
Ulcer healing time 853
Healed <3 months 454 (53.2%) 177 (56.0%) 29 (54.7%) 115 (47.5%) 43 (63.2%) 19 (46.3%) 71 (53.4%)
Healed 3–12 months 222 (26.0%) 75 (23.7%) 10 (18.9%) 71 (29.3%) 15 (22.1%) 10 (24.4%) 41 (30.8%)
Not healed at 12 months 177 (20.8%) 64 (20.3%) 14 (26.4%) 56 (23.1%) 10 (14.7%) 12 (29.3%) 21 (15.8%) 0.188
Treatment
Debrided Ulcer 849 765 (90.1%) 295 (93.4%) 45 (86.5%) 206 (86.2%) 61 (89.7%) 35 (85.4%) 123 (92.5%) 0.063
Dressing Appropriate 845 820 (97.0%) 303 (96.5%) 51 (98.1%) 230 (96.2%) 66 (98.5%) 39 (97.5%) 131 (98.5%) 0.766
Antibiotics Prescribed 851 58 (6.8%) 19 (6.0%) 1 (1.9%) 23 (9.6%) 6 (8.8%) 4 (9.8%) 5 (3.8%) 0.146
Offloading Optimum 851 395 (46.4%) 138 (43.9%) 24 (45.3%) 123 (50.8%) 25 (36.8%) 12(29.3%)** 73 (54.9%) 0.016*
Footwear Appropriate 848 505 (59.6%) 206 (65.2%) 31 (58.5%) 131 (54.8%) 36 (53.7%) 17 (42.5%)** 84 (63.2%) 0.024*
Patient Educated 851 843(99.1%) 314 (99.7%) 53 (100%) 238 (98.8%) 67 (98.5%) 39 (95.1%) 132 (99.2%) 0.104
Foot Infection Incidence
All foot ulcer patients 853 342 (40.1%) 133 (42.1%) 14 (26.4%) 106 (43.8%) 22 (32.4%) 13 (31.7%) 54 (40.6%) 0.111
Ulcer healing time 853
Healed <3 months 454 147 (32.4%) 67 (37.9%) 8 (27.6%) 40 (34.8%) 10 (23.3%) 3 (15.8%) 19 (26.8%) 0.152
Healed 3–12 months 222 124 (55.9%) 40 (53.3%) 4 (40.0%) 41 (57.7%) 8 (53.3%) 5 (50.0%) 26 (63.4%) 0.785
Not healed at 12 months 177 71 (40.1%) 26 (40.6%) 2 (14.3%) 25 (44.6%) 4 (40.0%) 5 (41.7%) 9 (42.9%) 0.487
* p < 0.05 for ANOVA (continuous) or Pearson’s chi-squared (categorical)
** Group(s) identified to be different to other groups using p < 0.05 for adjusted Post hoc tests (continuous) or p < 0.005 Fishers exact test with Bonferroni
corrections (categorical)
a HbA1c mmol/mol IFFC converted from HbA1c % NGSP
b CKD is a combination of CKD and ESKD (End Stage Kidney Disease)
c Ulcer area was measured by multiplying the longest edge x the widest edge in mm
d Deep ulcer is an ulcer scoring a 2 or 3 on the University of Texas Diabetic Wound Classification System
BGL>15 mmol/L: Blood Glucose Levels exceeding 15 mmol/L; CKD: Chronic Kidney Disease; CVD: Cardiovascular Disease; GP: General Practitioner;
mm2: millimetres squared; PAD: Peripheral Arterial Disease; SD: Standard deviation.
https://doi.org/10.1371/journal.pone.0177916.t001
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Table 2. Univariate analysis for patients developing an infection of a diabetic foot ulcer (number (%) unless otherwise stated).
n All No
Infection
Infection p Value
Patients 720 720 432(60.0%) 288(40.0%)
Demographics
Age years (SD) 720 62.7(12.7) 63.9(12.5) 61.0(12.9) 0.003*
Male sex 716 491 (68.6%) 305 (71.3%) 186 (64.6%) 0.071*
Indigenous 507 66 (13.0%) 38 (13.1%) 28 (12.9%) 1.000
Social Determinants
Socioeconomic Status 714
Most disadvantaged 172 (24.1%) 105 (24.5%) 67(23.5%)
Second most disadvantaged 153 (21.4%) 96 (22.4%) 57(20.0%)
Middle 108 (15.1%) 69 (16.1%) 39(13.7%)
Second least disadvantaged 208 (29.1%) 112 (26.1%) 96(33.7%)
Least disadvantaged 73 (10.2%) 47 (11.0%) 26(9.1%) 0.276
Geographic Remoteness 714
Major city 305 (42.7%) 174 (40.6%) 131(46.0%)
Inner regional area 143 (20.0%) 86 (20.0%) 57(20.0%)
Outer regional area 170 (23.8%) 104 (24.2%) 66(23.2%)
Remote area 53 (7.4%) 37 (8.6%) 16(5.2%)
Very remote area 43 (6.0%) 28 (6.5%) 15(5.3%) 0.434
Diabetes History
Type 2 diabetes 720 657 (91.3%) 397 (91.9%) 260 (90.3%) 0.536
Duration years (SD) 360 19.7 (11.1) 19.6 (11.3) 19.8(10.8) 0.864
HbA1c % (SD) 205 8.5(2.1) 8.5(2.2) 8.4(1.8) 0.571
HbA1c mmol/mol a 205 69 69 68 0.571
BGL >15mmol/L 651 121 (18.6) 74 (18.9%) 47 (18.1%) 0.895
Medical History
Hypertension 720 205 (28.5%) 131 (30.3%) 74 (25.7%) 0.206
Dyslipidaemia 720 134 (18.6%) 83 (19.2%) 51 (17.7%) 0.681
CVD 720 89 (12.4%) 55 (12.7%) 34 (11.8%) 0.799
CKD b 720 57 (7.9%) 34 (7.9%) 23 (8.0%) 1.000
Smoker 720 37 (5.1%) 21 (4.9%) 16 (5.6%) 0.809
Past Foot Treatment
Yes 720
Podiatrist 720 672 (93.3%) 402 (93.1%) 270 (93.8%) 0.831
GP 720 19 (2.6%) 12 (2.8%) 7 (2.4%) 0.962
Surgeon 720 13 (1.8%) 10 (2.3%) 3 (1.0%) 0.331
Physician 720 20 (2.8%) 14 (3.2%) 6 (2.1%) 0.487
Nurse 720 49 (6.8%) 26 (6.0%) 23 (8.0%) 0.381
Orthotist 720 8 (1.1%) 5 (1.2%) 3 (1.0%) 1.000
Other 720 20 (2.8%) 12 (2.8%) 8 (2.8%) 1.000
Foot Disease History
Previous foot ulcer 720 488 (67.8%) 270 (62.5%) 218 (75.7%) <0.001*
Previous amputation 719 209 (29.1%) 115 (26.7%) 94 (32.6%) 0.101
Foot Risk Factors
Peripheral Neuropathy 718 611 (85.1%) 353 (82.1%) 258 (89.6%) 0.008*
PAD 717 327 (45.6%) 194 (45.2%) 133 (46.2%) 0.860
Foot deformity 715 452 (63.2%) 254 (59.2%) 198 (69.2%) 0.008*
(Continued )
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To our knowledge we are the first to investigate the incidence of developing infection in
patients with different types of DFU and interestingly we found no differences. A recent previ-
ous study examining the prevalence of infection in different types of DFU also reported no
Table 2. (Continued)
n All No
Infection
Infection p Value
Acute Charcot Foot 712 18 (2.5%) 7 (1.6%) 11 (3.9%) 0.108
Foot Ulcer Characteristics
Ulcer area mm2 (SD) c 624 249.2(629.9) 234.8(670.0) 270.1(567.2) 0.493
Deep ulcer d 711 55 (7.7%) 22 (5.2%) 33(11.6%) 0.003*
Ulcer healing time 720
Healed <3 months 383 (53.2%) 255 (59.0%) 128 (44.4%)
Healed 3–12 months 181 (25.1%) 83 (19.2%) 98 (34.0%)
Not healed at 12 months 156 (21.7%) 94 (21.8%) 62 (21.5%) <0.001*
Treatment
Debrided Ulcer 716 642 (89.7%) 379 (88.1%) 263 (92.0%) 0.129
Dressing Appropriate 712 689 (96.8%) 410 (95.8%) 279 (98.2%) 0.112
Antibiotics Prescribed 718 53 (7.4%) 31 (7.2%) 22 (7.7%) 0.927
Offloading Optimum 718 322 (44.8%) 189 (44.0%) 133 (46.2%) 0.609
Footwear Appropriate 715 421 (58.9%) 258 (60.1%) 163 (57.0%) 0.447
Patient Educated 718 711 (99.0%) 427 (99.1%) 284 (99.0%) 1.000
* p < 0.1
a HbA1c mmol/mol IFFC converted from HbA1c % NGSP
b CKD is a combination of CKD and ESKD (End Stage Kidney Disease)
c Ulcer area was measured by multiplying the longest edge x the widest edge in mm
d Deep ulcer is an ulcer scoring a 2 or 3 on the University of Texas Diabetic Wound Classification System
BGL>15 mmol/L: Blood Glucose Levels exceeding 15 mmol/L; CKD: Chronic Kidney Disease; CVD: Cardiovascular Disease; GP: General Practitioner;
mm2: millimetres squared; PAD: Peripheral Arterial Disease; SD: Standard deviation.
https://doi.org/10.1371/journal.pone.0177916.t002
Table 3. Independent risk factors for developing an infection of a diabetic foot ulcer.
Risk Factor Odds Ratio (95% CI) p Value
Age (years) 0.98 (0.97–0.99) 0.002*
Female 1.52 (1.08–2.14) 0.016*
Peripheral Neuropathy 1.77 (1.09–2.86) 0.022*
Foot Deformity 1.44 (1.02–2.04) 0.039*
Previous Foot Ulcer 1.66 (1.16–2.36) 0.005*
Deep Ulcer 2.16 (1.19–3.93) 0.011*
Ulcer healing time <0.001*
Healed <3 months Referent
Healed 3–12 months 2.26 (1.55–3.29) <0.001*
Not healed at 12 months 1.20 (0.80–1.81) 0.373
Model Results: Pseudo R2: 0.120;
Omnibus: df = 8, p = <0.001
Missing: 17 (2.4%);
H&L: p = 0.088
* p < 0.05
df: degrees of freedom; H&L: Hosmer and Lemeshow Goodness of Fit Test; Missing: Excluded missing
cases; Omnibus: Omnibus Tests of Model Coefficients; Pseudo R2: Nagelkerke R2.
https://doi.org/10.1371/journal.pone.0177916.t003
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differences [28]. This previous study reported very similar patient characteristics for those
patients with different types of DFU to our study which also increases the potential generalisa-
bility of our findings [28]. Additionally, our overall DFU patient characteristics were very simi-
lar to those reported in other large international DFU studies, which further increases the
generalisability of our findings [3, 8–10]. Lastly, our reported socio-demographic characteris-
tics were very similar to the socio-demographic characteristics reported for the general Austra-
lian population [14, 19, 20]. Overall, these generalizable findings indicate that all clinicians
treating patients with any type of DFU need to be incredibly vigilant to prevent infection and
the subsequent significant risk of hospitalisation and amputation [5].
The risk factors we identified for developing foot infection in a large homogenous unin-
fected DFU population were similar to those identified in other studies investigating more het-
erogeneous DFU populations [5, 11], with perhaps some novel exceptions. Our identified risk
factors with greatest odds of developing infection were highly consistent with these previous
studies, including ulcers healed>3months, deep ulcers, peripheral neuropathy, foot deformity
and previous ulcer history [5, 11]. It is not surprising that those DFUs that were deepest and
had not healed for a longer duration were the leading risk factors for developing soft tissue
infection as they expose a greater volume of soft tissue to infective organisms for a longer
period of time [5, 29]. Additionally, it is not surprising that DFU patients with peripheral neu-
ropathy and its resultant lack of protective sensation and immunopathy that contribute to
delayed local inflammatory responses to infective organisms [30] is also a leading risk factor
for developing diabetic foot infection [11]. Whilst foot deformity has not been specifically
identified in previous studies, high plantar pressures have been [11] and foot deformity is
often used as a surrogate marker of high plantar pressures [22]. Again high plantar pressures,
especially in combination with neuropathy and deep ulcers, could be reasonably expected
to expose a great volume of soft tissue that has limited inflammatory response to infective
organisms [11]. Lastly, ours and previous studies did not capture participant’s history of previ-
ous diabetic foot infection [5, 11]; however, considering the high prevalence of infections in
DFUs [3–5, 7–10], it is most probable that the identified risk factor of a previous DFU is also
surrogate marker of a previous diabetic foot infection history [5, 11]. Thus, it is not surprising
that a history of any pathology is a risk factor for future pathology, in this case diabetic foot
infection.
The novel risk factors identified in our study were that of younger age and female gender.
To our knowledge, age or gender has not been previously identified as a risk factor for soft tis-
sue diabetic foot infection [5, 11]. In contrast to younger age, many studies have reported
older age to be a risk factor for developing poor DFU outcomes [28, 31, 32]. However, one
large previous study reported an association with younger age in patients with diabetes devel-
oping osteomyelitis [33]. Additionally, the mean ages reported from previous studies investi-
gating large populations of DFU patients (approximately 65 years [8, 29, 31]) have generally
been older when compared to studies investigating large populations of infected DFU patients
(approximately 55 years [11, 33, 34]). It could be hypothesised that younger patients with
equivalent DFUs are more physically active for longer durations then their older counterparts
which may increase their exposure to infective organisms for longer durations. Also in contrast
to female gender, it has been male gender that has been consistently reported to be a risk factor
for the development of poor DFU outcomes [11, 29, 31, 32]. However, females have been
reported to be at higher risk of other infections in patients with diabetes (such as different uri-
nary tract infections) [35, 36] and perhaps female patients with diabetes are more susceptible
to infection in general than males. Interestingly, recently published findings from a large retro-
spective analysis of outpatients with diabetes in the United States also reports patients with
infected DFU were more likely to be younger and female compared to those with uninfected
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DFU [37]. Overall, these findings suggest the demographic risk factors for developing a DFU
may be different to those for developing an infection of a DFU, and thus, more research inves-
tigating why these risk factors may be different is recommended
Interestingly, no other characteristics were identified as risk factors for infection in this
study. This is somewhat surprising considering other studies have identified PAD in particular
to be a risk factor for diabetic foot infection [5, 11]. However, we hypothesise that, due to the
heterogeneous populations investigated by these previous studies, PAD was more likely a risk
factor for DFU [2–4] rather than diabetic foot infection in someone who has already developed
a DFU. We suggest that once PAD has contributed to the development of a DFU, it is then the
depth of tissue involvement, the duration of exposure, coupled with the immunopathy and
lack of protective sensation from peripheral neuropathy that are the real culprits for develop-
ing a foot infection in the first instance [11, 30]. However, we suggest that once a DFU has
become infected then underlying PAD may accelerate the progression of the infection and
increase the risk of subsequent hospitalisation and amputation [3, 4].
Other large international population-based studies have identified socio-economic status,
geographical remoteness and ethnicity to be associated with poor DFU outcomes [38, 39].
Two recent Australian studies also identified specific associations between indigenous Austra-
lians and DFU [40, 41]. However, our study which included patients from the diverse socio-
demographic, geographical and indigenous backgrounds found in Australia [14, 32] could not
find any associations with developing infection. Our findings were consistent with Peters et al
that could not find any association between socio-demographic factors and diabetic foot infec-
tion in the United States [11]. Additionally, they were consistent with a large study by Holman
et al (2015) investigating DFU healing outcomes across the United Kingdom who also could
not find any association with socio-demographic factors [10]. Holman hypothesised that the
universal best practice standard of DFU care provided to patients attending the services in
their study may have counteracted any typical socio-demographic factor influence on negative
DFU outcomes [10] and our findings seem to support their hypothesis.
Although, our risk factor findings were relatively consistent with previous studies [5, 11],
our study is the first to report the variance predicted from our model containing these risk fac-
tors. Collectively our multivariate model explained approximately 12% of the predicted vari-
ance for developing infection according to our reported pseudo R2. This predicted variance
indicates that there must be other risk factors for developing infection in patients with DFU
that were not investigated in our study. Thus, we firstly recommended that any future studies
investigate the risk factors identified in our study in addition to a range of other diabetes sever-
ity, physical activity, plantar pressures, microbial isolates, inflammatory makers and treatment
factors in both best practice and standard care settings [42]. Secondly, it is recommended that
future studies investigate for any differences in risk factor profiles for developing mild, moder-
ate and severe diabetic foot infection outcomes. Lastly, it is recommended that clinicians man-
aging patients with a DFU should be particularly vigilant in their provision of best practice
care if those patients present with a DFU that is deep, have a previous ulcer history, peripheral
neuropathy, foot deformity, are of younger age or female. This vigilance should be heightened
again if the ulcer has not healed by 3 months. Any improved strategies to prevent infection in
patients with DFU should also begin to reduce the significant burden of hospitalisation and
amputation in these patients.
Limitations and strengths
This study had a number of limitations. First, it was secondary analysis of a prospective state-
wide clinical diabetic foot database that primarily collects DFU healing and recurrence
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outcomes for clinical benchmarking and research purposes and not primarily for infection
outcomes. However it could be argued that this database’s primary focus on DFU also provides
some strength to our study. Second, much missing data was reported in relation to the specific
diabetes severity variables (diabetes duration, HbA1c) and for this reason we did not include
them in our multivariate models. Therefore, our study was unable to properly investigate if
these variables were risk factors for infected DFU. Third, we defined PAD using a toe pressure
of<70mmHg, which is arguably a lower threshold than the<0.8 ankle brachial index used
by aforementioned studies investigating risk factors for infection [5, 11], and this may have
meant we over-reported PAD. Fourth, we excluded patients that did not have infection status
recorded at baseline or during follow up; however, the proportion of patients fitting these cri-
teria was small. Fifth, we followed up patients whose DFU had not healed for only 12-months
and this may have contributed to an underestimation of our infection incidence for those not
healed at 12-months. Sixth, we were only able to obtain dichotomous data reporting if an
infection occurred prior to healing and not the date of infection. Thus, like other papers in this
field [5, 11] we were able to report incidence rates and perform logistic regression; however,
we were unable to report time-to-event survival analyses which may have provided additional
more detailed findings. Seventh, although the QHRFF best practice protocol used in this study
aligns with national diabetic foot guideline recommendations [22] and recommends at least
fortnightly care for DFU patients [12], we can only assume this best practice follow up care
was provided. Additionally, we may have missed some infections and other treatments (such
as some revascularisation procedures) that were potentially managed elsewhere between visits.
Last, no information about microbial isolates or inflammatory markers was collected to deter-
mine their association with infection development [42].
This study also had a number of strengths. First, this study’s sample size was the largest of
any study longitudinally investigating DFU patients for infection [5, 11], was comparable in
sample size to other large longitudinal studies investigating other DFU outcomes [5, 8–10] and
had a very high retention rate. Second, the characteristics of included DFU patients and DFU
types in our study were generalizable to other regions as we reported very similar characteris-
tics to those reported in other large DFU studies [3, 8–10]. Third, the included patients in our
study were representative of the diverse socio-demographic backgrounds reported in the gen-
eral Australian population [14, 19, 20]. Fourth, all variables were captured on a data collection
instrument and database that has been reported to be valid and reliable to collect DFU-related
variables, including infection [12, 13, 15]. Fifth, DFU patients were treated according to a best
practice protocol on their first visit [12, 22]. Furthermore, this protocol recommends at least
fortnightly clinical care and data collection using the QHRFF for DFU patients [22], and thus,
it is assumed patients also received frequent best practice care and data collection during fol-
low up [12]. Last, we identified independent risk factors for diabetic foot infection that were
adjusted for age, sex and ulcer healing time using a widely recommended multivariate logistic
regression analysis model [26, 27], which makes the findings of our study comparable to other
similar studies of diabetic foot infection [5, 11]. However, an additional strength of our study’s
analysis was that we were the first to report the approximate variance that our identified risk
factors collectively predicted for diabetic foot infection.
Conclusions
This study of a large representative Australian population of patients presenting to Diabetic
Foot Services with uninfected diabetic foot ulcers, confirms that a considerable proportion will
develop an infection prior to healing, regardless of their ulcer type. Risk factors for developing
an infection included initially presenting with a deep ulcer, having had a previous ulcer, having
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peripheral neuropathy, having a foot deformity, being of younger age and female. In addition an
ulcer that had not healed<3 months of this presentation doubled the odds of developing infec-
tion. It is recommended that future investigations in this population focus on demographic,
diabetes severity, physical activity, microbial isolates and inflammatory marker explanatory vari-
ables and different diabetic foot infection severity outcomes. The results of this study should
assist to improve risk profiling and treatment of diabetic foot ulcers to prevent future infections.
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